✦ LIBER ✦

The Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial: Rationale and Design

✍ Scribed by OGIHARA, Toshio; MATSUZAKI, Masunori; MATSUOKA, Hiroaki; SHIMAMOTO, Kazuaki; SHIMADA, Kazuyuki; RAKUGI, Hiromi; UMEMOTO, Seiji; KAMIYA, Akira; SUZUKI, Norihiro; KUMAGAI, Hiroo

Book ID: 111776624
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 76 KB
Volume: 28
Category: Article
ISSN: 0916-9636
DOI: 10.1291/hypres.28.331

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and design of the avoiding car

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: The first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension

✍ Kenneth A. Jamerson; George L. Bakris; Chuan-Chuan Wun; Björn Dahlöf; Martin Lef 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB

Design of the accomplish (avoiding cardi

Design of the accomplish (avoiding cardiovascular events through combination therapy in patients living with systolic hypertension) trial

✍ Kenneth A. Jamerson; George L. Bakris; Janice G. Douglas; Bertram Pitt; Eric Vel 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 35 KB

Stent revascularization for the preventi

Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial

✍ Christopher J. Cooper; Timothy P. Murphy; Alan Matsumoto; Michael Steffes; David 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 255 KB

2.P.286 Rationale and design of a trial

2.P.286 Rationale and design of a trial to evaluate the impact of continuous combined hormone replacement therapy on the cardiovascular disease risk profile

✍ Michael H. Davidson; Kevin C. Maki; Mary Sue Cyrowski; Ann C. Maki; Cheryl Synec 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 172 KB

The Diabetes Subgroup Baseline Character

The Diabetes Subgroup Baseline Characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) Trial

✍ George Bakris; Allen Hester; Michael Weber; Bjorn Dahlof; Bert Pitt; Eric Velasq 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 236 KB

Rationale and design of ACTIVE: The atri

Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

✍ The ACTIVE Steering Committee 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 200 KB